ATE151288T1 - N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt - Google Patents

N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt

Info

Publication number
ATE151288T1
ATE151288T1 AT92101873T AT92101873T ATE151288T1 AT E151288 T1 ATE151288 T1 AT E151288T1 AT 92101873 T AT92101873 T AT 92101873T AT 92101873 T AT92101873 T AT 92101873T AT E151288 T1 ATE151288 T1 AT E151288T1
Authority
AT
Austria
Prior art keywords
acetyl
treatment
cataract
pharmaceutical composition
composition containing
Prior art date
Application number
AT92101873T
Other languages
English (en)
Inventor
Francesco Santangelo
Giorgio Bertolini
Franco Pellacini
Luciano Soldati
Annibale Gazzaniga
Cesare Casagrande
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE151288T1 publication Critical patent/ATE151288T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT92101873T 1991-02-21 1992-02-05 N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt ATE151288T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI910456A IT1249047B (it) 1991-02-21 1991-02-21 Composizione farmaceutica per il trattamento della cataratta

Publications (1)

Publication Number Publication Date
ATE151288T1 true ATE151288T1 (de) 1997-04-15

Family

ID=11358690

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92101873T ATE151288T1 (de) 1991-02-21 1992-02-05 N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt

Country Status (6)

Country Link
US (1) US5519054A (de)
EP (1) EP0499882B1 (de)
JP (1) JP3457687B2 (de)
AT (1) ATE151288T1 (de)
DE (1) DE69218816T2 (de)
IT (1) IT1249047B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1258781B (it) * 1992-01-16 1996-02-29 Zambon Spa Composizione farmaceutica oftalmica contenente n-acetilcisteina e polivinilalcol
DE69434617D1 (de) * 1993-11-19 2006-04-06 Univ Sydney Verfahren zur prophylaxe oder kontrolle des katarakts
US5686450A (en) * 1995-06-07 1997-11-11 Alcon Laboratories, Inc. Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
AU1837197A (en) * 1996-01-26 1997-08-20 United States of America, represented by the Secretary, Department of Health and Human Services, The National Institutes of Health, The Hydroxylamine compositions for the prevention or retardation of cataracts
US6231875B1 (en) 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
AU3212099A (en) * 1998-03-31 1999-10-18 Johnson & Johnson Consumer Companies, Inc. Method for increasing the permeability of horny human tissue
AU7330200A (en) * 1999-08-09 2001-05-10 Webb-Waring Institute For Biomedical Research A method for the treatment of ocular oxidative stress
FR2811550B1 (fr) * 2000-07-11 2003-02-14 Oreal Composition a base de vitamines et de sels mineraux, pour diminuer la chute des cheveux et/ou favoriser la repousse des cheveux
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
JP5796881B2 (ja) * 2008-02-07 2015-10-21 マーケット ユニバーシティー 統合失調症を治療するため及び薬物渇望を低減するためのシステイン及びシスチンプロドラッグ
WO2013163545A1 (en) * 2012-04-26 2013-10-31 Sentient Lifesciences, Inc. Use of n-acetylcysteine amide in the treatment of disease and injury
WO2018174839A1 (en) * 2017-03-18 2018-09-27 Nguyen Mark Quang Cysteine, n-acetylcysteine and penicillamine prodrugs, pharmaceutical compositions thereof, and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR4619M (de) * 1965-02-01 1966-11-28
BE744952A (en) * 1969-01-28 1970-07-27 Bristol Myers Co Treatment to maintain the urinary - passages clear
JPS5592315A (en) * 1979-01-05 1980-07-12 Santen Pharmaceut Co Ltd Remedy for cataract
JPS5649879A (en) * 1979-10-01 1981-05-06 Furukawa Electric Co Ltd Electrically heating furnace
BE901885A (fr) * 1985-03-06 1985-07-01 Bruschettini Srl Composition pharmaceutique sous forme de lotion ophtalmique et son procede de preparation.
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
EP0276317B1 (de) * 1986-07-07 1993-03-17 Teijin Limited Gamma-l-glutamyl-l-cysteinethylester und arzneimittel, die dieses als aktives mittel enthalten
FR2651129B1 (fr) * 1989-08-31 1991-12-13 Bfb Etud Rech Eperimentales Nouveaux derives de cysteine; compositions pharmaceutiques ou cosmetiques en contenant.

Also Published As

Publication number Publication date
JPH0585933A (ja) 1993-04-06
ITMI910456A0 (it) 1991-02-21
DE69218816T2 (de) 1997-07-17
EP0499882B1 (de) 1997-04-09
ITMI910456A1 (it) 1992-08-21
JP3457687B2 (ja) 2003-10-20
EP0499882A1 (de) 1992-08-26
US5519054A (en) 1996-05-21
DE69218816D1 (de) 1997-05-15
IT1249047B (it) 1995-02-11

Similar Documents

Publication Publication Date Title
ES2084944T3 (es) Amidas terapeuticas.
ATE151288T1 (de) N-acetyl-cysteine derivate enthaltende pharmazeutische zusammensetzung zur behandlung von katarakt
NO913684L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
ATE201671T1 (de) Chinolon und acridinon derivate zur behandlung der harninkontinenz
SE8404065D0 (sv) Novel biologically active compounds
ATE170852T1 (de) Benzolsulfonamid-derivate zur behandlung der blaseninstabilität
SE8600658D0 (sv) Novel composition of matter
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
DE69402004D1 (de) Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen
FI101849B1 (fi) Antimikrobiset koostumukset ja niiden käyttö silmälääkkeiden säilömiseksi ja piilolinssien hoitamiseksi
DE69418110D1 (de) N-Heteroaryl substituierte Propanamid-Derivate brauchbar zur Behandlung cardiovascularer Krankheiten
ATE88176T1 (de) 2-hydroxy-3-aryloxy-propylaminderivate mit kardiovaskulaerer wirkung.
DE69409464D1 (de) Derivate von N-epsilon Alkoxy- oder Alkenoxy-carbonyl-Lysin, ihre Herstellung und Verwendung in kosmetischen, pharmazeutischen, hygienischen und nahrhaften Zusammensetzungen
NO913683L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
NO913685D0 (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
ATE243219T1 (de) 9a, 11b-dehydro derivative von 9-oxime-3-keto-6-0-methylerythromycin
ATE92037T1 (de) Kardiovaskulaer aktive verbindungen.